Extendicare Inc (EXE.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Extendicare Inc (EXE.TO)

30.69

-0.11 (0.34%)

as of Aug 31, 2026, 7:33:18 pm Market Open.

171 watching

Investor Insights

Aug 31, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Extendicare Inc. (EXE-T) is highlighted for its strategic positioning within the growing home healthcare sector, effectively capitalizing on demographic trends favoring increased demand for senior care services. The company’s management appears proficient in maintaining healthy margins, particularly as funding from the Ontario government continues to rise. While some experts believe the stock is poised for further growth, they caution about current valuations reflecting high expectations. The company's unique structure as a corporation compared to typical REITs permits a different financial model, making it an intriguing consideration. Furthermore, there are mixed sentiments regarding the stock's immediate prospects, with some experts favoring alternative stocks in the same market due to concerns over potential overvaluation.

Consensus

Cautious

Valuation

Fair Value

Similar

CSH.UN

DON'T BUY

Model price is around the $7 area. Overvalued.

Wealthica Track your Stocks in your Watch List

DON'T BUY

Has been a multi year disappointment. A lot of government regulations. Costs are high.

DON'T BUY

US state legislatures limit their revenues. For demographics, would prefer retirement homes.

BUY

A bit of a value play right now. Has a big asset in some hidden real estate assets. Solid.

WEAK BUY

Bad corporate governance.

DON'T BUY

Growth has not been as great as expected. Demographics for nursing facilities is too far off.

DON'T BUY

Fair market value is $3.

DON'T BUY

Tpp exposed to the swings of the operating income.

WEAK BUY

Prefers Sunrise instead.

BUY

Good story. Has been in and out of this stock several times. At a good price now.

WEAK BUY

Government issues in US could create severe problems.

STRONG BUY

Very profitable. Should continue to turn around

TOP PICK

Have sold some assets to pay down debt. Trades at a discount to its US peers.

BUY

Has undergone a significant turn around. Refocusing from Florida operations into Ontario.

DON'T BUY

Too overleveraged.

Showing 211 to 225 of 237 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Kevin Simpson

Capital Wealth Planning

Jim Lebenthal

Cerity Partners

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Brianne Gardner

Raymond James

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Extendicare Inc (EXE.TO)